Trials / Active Not Recruiting
Active Not RecruitingNCT05498103
Use of Methazolamide to Lower Intraocular Pressure
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of methazolamide, 25 mg or 50 mg tablets once a day for a week than twice a day for a week, on lowering intraocular pressure and the safety of methazolamide.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methazolamide 25 MG | 25 mg tablets |
| DRUG | Methazolamide 50 MG | 50 mg tablets |
Timeline
- Start date
- 2023-02-17
- Primary completion
- 2023-09-14
- Completion
- 2024-12-01
- First posted
- 2022-08-11
- Last updated
- 2024-02-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05498103. Inclusion in this directory is not an endorsement.